Literature DB >> 17555751

Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer.

Evangelos G Papanikolaou1, Efstratios M Kolibianakis, Cristina Pozzobon, Parikshit Tank, Herman Tournaye, Claire Bourgain, Andre Van Steirteghem, Paul Devroey.   

Abstract

Four hundred eighty-two patients undergoing single ET with GnRH-antagonist/recFSH protocol were analyzed. The incidence of premature luteinization (P above 1.5 ng/mL on the day of hCG administration) was 18.2%. Even modest rises of P in the follicular phase have detrimental effect on the implantation potential of a good-quality cleavage stage embryo. On the contrary, premature luteinization in the blastocyst subgroup had no effect on the pregnancy outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17555751     DOI: 10.1016/j.fertnstert.2006.12.064

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  36 in total

1.  Quality of embryos transferred and progesterone levels are the most important predictors of live birth after fresh embryo transfer: a retrospective cohort study.

Authors:  Qianfang Cai; Fei Wan; Dina Appleby; Linli Hu; Hanwang Zhang
Journal:  J Assist Reprod Genet       Date:  2013-11-08       Impact factor: 3.412

Review 2.  Adverse effect of prematurely elevated progesterone in in vitro fertilization cycles: a literature review.

Authors:  Michael B Evans; Mae W Healy; Alan H DeCherney; Micah J Hill
Journal:  Biol Reprod       Date:  2018-07-01       Impact factor: 4.285

3.  Does elevated progesterone on day of oocyte maturation play a role in the racial disparities in IVF outcomes?

Authors:  Micah J Hill; G Donald Royster; Mansi Taneja; Mae Wu Healy; Shvetha M Zarek; Alicia Y Christy; Alan H DeCherney; Eric Widra; Kate Devine
Journal:  Reprod Biomed Online       Date:  2016-11-16       Impact factor: 3.828

Review 4.  The curious case of premature luteinization.

Authors:  Apostolos Kaponis; Elpiniki Chronopoulou; George Decavalas
Journal:  J Assist Reprod Genet       Date:  2018-07-26       Impact factor: 3.412

5.  Progesterone levels on the hCG day and outcomes in vitro fertilization in women with polycystic ovary syndrome.

Authors:  Cuiying Peng; Zifen Guo; Xingyu Long; Guangxiu Lu
Journal:  J Assist Reprod Genet       Date:  2012-05-03       Impact factor: 3.412

6.  Elevated progesterone-to-estradiol ratio versus serum progesterone alone for predicting poor cycle outcome with in vitro fertilization.

Authors:  Martin D Keltz; Daniel E Stein; Inna Berin; Josh Skorupski
Journal:  J Reprod Med       Date:  2012 Jan-Feb       Impact factor: 0.142

7.  Osteopontin and Integrin αvβ3 Expression during the Implantation Window in IVF Patients with Elevated Serum Progesterone and Oestradiol Level.

Authors:  Z He; Y Ma; L Li; J Liu; H Yang; C Chen; N Lin; Y Bai; R Ma; R Li; Z Wu; J Qiao
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-06       Impact factor: 2.915

8.  Does subtle progesterone rise on the day of HCG affect pregnancy rate in long agonist ICSI cycles?

Authors:  Hisham Ali Saleh; Mervat Sheikh El-Arab Omran; Mohamed Draz
Journal:  J Assist Reprod Genet       Date:  2009-05-21       Impact factor: 3.412

9.  Is it the egg or the endometrium? Elevated progesterone on day of trigger is not associated with embryo ploidy nor decreased success rates in subsequent embryo transfer cycles.

Authors:  Jason D Kofinas; Holly Mehr; Nandita Ganguly; Yelena Biley; Svetlana Bochkovsky; David McCulloh; Jamie Grifo
Journal:  J Assist Reprod Genet       Date:  2016-06-04       Impact factor: 3.412

Review 10.  Revisiting debates of premature luteinization and its effect on assisted reproductive technology outcome.

Authors:  Reda S Hussein; Ihab Elnashar; Ahmed F Amin; Hisham A Abou-Taleb; Ahmed M Abbas; Ahmed M Abdelmageed; Tarek Farghaly; Yulian Zhao
Journal:  J Assist Reprod Genet       Date:  2019-10-25       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.